David A. Siegel Natera, Inc. Transaction History

Two Sigma Advisers, LP

$47 Billion
Q3 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Natera, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 96,700 shares of NTRA stock, worth $19.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

96,700

Previous 152,600 36.63%

Holding current value

$19.8 Million

Previous $25.8 Million 39.62%

% of portfolio

0.03%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$133.66 - $181.11 $7.47 Million - $10.1 Million	-55,900 Reduced 36.63%	96,700 $15.6 Million
Q2 2025 Aug 14, 2025	BUY	$132.23 - $171.87 $687,596 - $893,724	5,200 Added 3.53%	152,600 $25.8 Million
Q1 2025 May 15, 2025	SELL	$132.63 - $177.0 $30.5 Million - $40.8 Million	-230,300 Reduced 60.97%	147,400 $20.8 Million
Q4 2024 Feb 14, 2025	BUY	$117.67 - $174.0 $7.34 Million - $10.9 Million	62,400 Added 19.79%	377,700 $59.8 Million
Q3 2024 Nov 14, 2024	BUY	$97.75 - $129.67 $8.79 Million - $11.7 Million	89,900 Added 39.88%	315,300 $40.1 Million

Q2 2024 Aug 14, 2024	BUY	$85.28 - $112.6 $19.2 Million - $25.4 Million	225,400 New	225,400 $24.4 Million
Q3 2023 Nov 14, 2023	SELL	$43.4 - $62.52 $6.96 Million - $10 Million	-160,400 Reduced 88.23%	21,400 $946,000
Q2 2023 Aug 14, 2023	SELL	$47.08 - $55.16 $6.53 Million - $7.65 Million	-138,600 Reduced 43.26%	181,800 $8.85 Million
Q1 2023 May 15, 2023	SELL	$36.57 - $58.29 $12.7 Million - $20.2 Million	-347,100 Reduced 52.0%	320,400 $17.8 Million
Q4 2022 Feb 14, 2023	SELL	$34.17 - $47.91 $5.38 Million - $7.55 Million	-157,500 Reduced 19.09%	667,500 $26.8 Million
Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $9.2 Million - $14.1 Million	-249,000 Reduced 23.18%	825,000 $36.2 Million
Q2 2022 Aug 15, 2022	SELL	$28.13 - $44.54 $2.54 Million - $4.02 Million	-90,300 Reduced 7.76%	1,074,000 $38.1 Million
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $32.9 Million - $99.1 Million	1,085,000 Added 1368.22%	1,164,300 $47.4 Million
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $9.31 Million - $12.8 Million	-107,900 Reduced 57.64%	79,300 $7.41 Million
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $33.1 Million - $41.7 Million	-330,000 Reduced 63.81%	187,200 $20.9 Million
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $6.08 Million - $8.45 Million	-70,600 Reduced 12.01%	517,200 $58.7 Million
Q1 2021 May 17, 2021	BUY	$91.47 - $124.36 $10.2 Million - $13.9 Million	111,600 Added 23.44%	587,800 $59.7 Million
Q4 2020 Feb 16, 2021	SELL	$66.66 - $111.74 $1.78 Million - $2.98 Million	-26,700 Reduced 5.31%	476,200 $47.4 Million
Q3 2020 Nov 16, 2020	SELL	$45.89 - $72.67 $5.3 Million - $8.4 Million	-115,600 Reduced 18.69%	502,900 $36.3 Million
Q2 2020 Aug 14, 2020	BUY	$26.36 - $49.86 $664,272 - $1.26 Million	25,200 Added 4.25%	618,500 $30.8 Million
Q1 2020 May 15, 2020	BUY	$17.27 - $40.17 $4.27 Million - $9.94 Million	247,400 Added 71.52%	593,300 $17.7 Million
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $4.72 Million - $5.93 Million	146,900 Added 73.82%	345,900 $11.7 Million
Q3 2019 Nov 14, 2019	SELL	$25.38 - $34.89 $1 Million - $1.38 Million	-39,500 Reduced 16.56%	199,000 $6.53 Million
Q2 2019 Aug 14, 2019	BUY	$17.75 - $27.58 $143,775 - $223,398	8,100 Added 3.52%	238,500 $6.58 Million
Q1 2019 May 15, 2019	BUY	$11.34 - $20.62 $733,698 - $1.33 Million	64,700 Added 39.05%	230,400 $4.75 Million
Q4 2018 Feb 14, 2019	BUY	$12.32 - $24.38 $480,480 - $950,820	39,000 Added 30.78%	165,700 $2.31 Million
Q3 2018 Nov 14, 2018	BUY	$18.82 - $28.96 $327,468 - $503,904	17,400 Added 15.92%	126,700 $3.03 Million
Q2 2018 Aug 14, 2018	BUY	$8.79 - $19.98 $960,746 - $2.18 Million	109,300 New	109,300 $2.06 Million

Others Institutions Holding NTRA

# of Institutions

754

Shares Held

126M

Call Options Held

1.13M

Put Options Held

449K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $19.8B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account